These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36715822)

  • 21. The WNT/β-catenin system in chronic kidney disease-mineral bone disorder syndrome.
    Zhang L; Adu IK; Zhang H; Wang J
    Int Urol Nephrol; 2023 Oct; 55(10):2527-2538. PubMed ID: 36964322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating Wnt/β-catenin signalling inhibitors and uraemic vascular calcifications.
    Yang CY; Chang ZF; Chau YP; Chen A; Yang WC; Yang AH; Lee OK
    Nephrol Dial Transplant; 2015 Aug; 30(8):1356-63. PubMed ID: 25817223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sclerostin and Dickkopf-1 in post-menopausal renal allograft recipients.
    Tomei P; Zaza G; Granata S; Gatti D; Fraccarollo C; Gesualdo L; Boschiero L; Lupo A
    Transplant Proc; 2014 Sep; 46(7):2241-6. PubMed ID: 25242761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biomarkers in WNT1 and PLS3 Osteoporosis: Altered Concentrations of DKK1 and FGF23.
    Mäkitie RE; Kämpe A; Costantini A; Alm JJ; Magnusson P; Mäkitie O
    J Bone Miner Res; 2020 May; 35(5):901-912. PubMed ID: 31968132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The suppressive effect of soluble Klotho on fibroblastic growth factor 23 synthesis in UMR-106 osteoblast-like cells.
    Ma L; Gao M; Wu L; Zhao X; Mao H; Xing C
    Cell Biol Int; 2018 Sep; 42(9):1270-1274. PubMed ID: 29851201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sclerostin, Osteocytes, and Wnt Signaling in Pediatric Renal Osteodystrophy.
    Laster M; Pereira RC; Noche K; Gales B; Salusky IB; Albrecht LV
    Nutrients; 2023 Sep; 15(19):. PubMed ID: 37836411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetes mellitus modifies the association between chronic kidney disease-mineral and bone disorder biomarkers and aortic stiffness in peritoneal dialysis patients.
    Huang HJ; Hsu BG; Wang CH; Tsai JP; Chen YH; Hung SC; Lin YL
    Sci Rep; 2024 Feb; 14(1):4554. PubMed ID: 38402283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Wnt/β-catenin pathway proteins in end-stage renal disease.
    Al-Hakeim HK; Asad HN; Maes M
    Biomark Med; 2021 Oct; 15(15):1423-1434. PubMed ID: 34554011
    [No Abstract]   [Full Text] [Related]  

  • 29. Active vitamin D and accelerated progression of aortic stiffness in hemodialysis patients: a longitudinal observational study.
    Fortier C; Mac-Way F; De Serres SA; Marquis K; Douville P; Desmeules S; Larivière R; Agharazii M
    Am J Hypertens; 2014 Nov; 27(11):1346-54. PubMed ID: 24695980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of the RANK/RANKL/OPG and Wnt/β-Catenin Systems in CKD Bone and Cardiovascular Disorders.
    Carrillo-López N; Martínez-Arias L; Fernández-Villabrille S; Ruiz-Torres MP; Dusso A; Cannata-Andía JB; Naves-Díaz M; Panizo S;
    Calcif Tissue Int; 2021 Apr; 108(4):439-451. PubMed ID: 33586001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between sclerostin levels and vascular outcomes in kidney transplantation patients.
    Koh HB; Ryu JH; Kim SS; Kim MG; Park JB; Kim CD; Kang KP; Ro H; Han SY; Huh KH; Yang J;
    J Nephrol; 2023 Sep; 36(7):2091-2109. PubMed ID: 37751127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Role of the morphogenetic proteins FGF-23 and Klotho and the glycoprotein sclerostin in the assessment of the risk of cardiovascular diseases and the prognosis of chronic kidney disease].
    Milovanova LY; Milovanov YS; Kudryavtseva DV; Markina MM; Milovanova SY; Kozlovskaya LV; Lebedeva MV; Beketov VD; Moiseev SV; Mukhin NA; Fomin VV; Svistunov AA
    Ter Arkh; 2015; 87(6):10-16. PubMed ID: 26281189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sclerostin levels associated with inhibition of the Wnt/β-catenin signaling and reduced bone turnover in type 2 diabetes mellitus.
    Gaudio A; Privitera F; Battaglia K; Torrisi V; Sidoti MH; Pulvirenti I; Canzonieri E; Tringali G; Fiore CE
    J Clin Endocrinol Metab; 2012 Oct; 97(10):3744-50. PubMed ID: 22855334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The FGF23-Klotho axis and cardiac tissue Doppler imaging in pediatric chronic kidney disease-a prospective cohort study.
    Tranæus Lindblad Y; Olauson H; Vavilis G; Hammar U; Herthelius M; Axelsson J; Bárány P
    Pediatr Nephrol; 2018 Jan; 33(1):147-157. PubMed ID: 28795324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CKD-induced wingless/integration1 inhibitors and phosphorus cause the CKD-mineral and bone disorder.
    Fang Y; Ginsberg C; Seifert M; Agapova O; Sugatani T; Register TC; Freedman BI; Monier-Faugere MC; Malluche H; Hruska KA
    J Am Soc Nephrol; 2014 Aug; 25(8):1760-73. PubMed ID: 24578135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sclerostin/Receptor Related Protein 4 and Ginkgo Biloba Extract Alleviates β-Glycerophosphate-Induced Vascular Smooth Muscle Cell Calcification By Inhibiting Wnt/β-Catenin Pathway.
    Wang J; Qiu X; Xu T; Sheng Z; Yao L
    Blood Purif; 2019; 47 Suppl 1(Suppl 1):17-23. PubMed ID: 30699436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of phosphate binder therapy on vascular stiffness in early-stage chronic kidney disease.
    Seifert ME; de las Fuentes L; Rothstein M; Dietzen DJ; Bierhals AJ; Cheng SC; Ross W; Windus D; Dávila-Román VG; Hruska KA
    Am J Nephrol; 2013; 38(2):158-67. PubMed ID: 23941761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Markers of bone remodeling are associated with arterial stiffness in renal transplanted subjects.
    Bargnoux AS; Vetromile F; Kuster N; Barberet J; Dupuy AM; Ribstein J; Mourad G; Cristol JP; Fesler P
    J Nephrol; 2015 Dec; 28(6):765-72. PubMed ID: 25920618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sclerostin blood levels before and after kidney transplantation.
    Bonani M; Rodriguez D; Fehr T; Mohebbi N; Brockmann J; Blum M; Graf N; Frey D; Wüthrich RP
    Kidney Blood Press Res; 2014; 39(4):230-9. PubMed ID: 25118597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum Sclerostin But Not DKK-1 Correlated with Central Arterial Stiffness in End Stage Renal Disease Patients.
    Wu CF; Hou JS; Wang CH; Lin YL; Lai YH; Kuo CH; Liou HH; Tsai JP; Hsu BG
    Int J Environ Res Public Health; 2020 Feb; 17(4):. PubMed ID: 32075016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.